New York, United States
OccamzRazor, founded in 2015 and headquartered in the United States, is at the forefront of integrating cutting-edge AI and machine learning technologies within the biotechnology sector.
The company's slogan, "OccamzRazor pioneers novel machine learning methods to increase success in drug discovery and development," encapsulates its core mission of revolutionizing drug discovery processes using advanced computational techniques.
The most recent financial milestone for OccamzRazor was a $6.10M Series A investment secured on 08 March 2022. This round was led by notable investors, including Valor Equity Partners, Lauder Partners, re.Mind Capital, and Jeff Dean.
Given its innovative approach and substantial backing, OccamzRazor is strategically positioned to make significant impacts within drug development, offering a compelling opportunity for potential investors interested in the convergence of AI and biotech.
